{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T07:09:11Z","timestamp":1765004951952,"version":"build-2065373602"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-025-06442-9","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T20:10:39Z","timestamp":1757362239000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fecal calprotectin as a marker of intestinal inflammation in pediatric cystic fibrosis patients"],"prefix":"10.1007","volume":"184","author":[{"given":"Damla G\u00f6k\u00e7eer","family":"Akbulut","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00fclin Ay\u015fe","family":"\u00d6zden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa Serdar","family":"Cantez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vildan","family":"Ertekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeynep","family":"Tamay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zlem","family":"Durmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"6442_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-14-133","volume":"14","author":"N Rumman","year":"2014","unstructured":"Rumman N, Sultan M, El-Chammas K, Goh V, Salzman N, Quintero D, Werlin S (2014) Calprotectin in cystic fibrosis. BMC Pediatr 14:133. https:\/\/doi.org\/10.1186\/1471-2431-14-133","journal-title":"BMC Pediatr"},{"issue":"1","key":"6442_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jcf.2017.06.008","volume":"17","author":"F Meyer","year":"2018","unstructured":"Meyer F, Regnault A, Bergougnoux A, Chiron R, Dalphin ML, Reix P (2018) Wireless capsule endoscopy in cystic fibrosis patients reveals small bowel inflammation. J Cyst Fibros 17(1):65\u201371. https:\/\/doi.org\/10.1016\/j.jcf.2017.06.008","journal-title":"J Cyst Fibros"},{"issue":"4","key":"6442_CR3","doi-asserted-by":"publisher","first-page":"979","DOI":"10.4049\/jimmunol.2001017","volume":"208","author":"TS Edwards","year":"2022","unstructured":"Edwards TS, Dickerhof N, Magon NJ, Paton LN, Sly PD, Kettle AJ (2022) Formation of calprotectin-derived peptides in the airways of children with cystic fibrosis. J Immunol 208(4):979\u2013990. https:\/\/doi.org\/10.4049\/jimmunol.2001017","journal-title":"J Immunol"},{"key":"6442_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jcf.2024.01.005","volume":"23","author":"AR Smyth","year":"2024","unstructured":"Smyth AR, Southern KW, Addy C, Burhan H, Collinson J, Dempster M, Denton M, Drevinek P, Duff AJ, Dyce P et al (2024) Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues. J Cyst Fibros 23:187\u2013202. https:\/\/doi.org\/10.1016\/j.jcf.2024.01.005","journal-title":"J Cyst Fibros"},{"issue":"8","key":"6442_CR5","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3345\/kjp.2019.00059","volume":"62","author":"SJ Jeong","year":"2019","unstructured":"Jeong SJ (2019) The role of fecal calprotectin in pediatric disease. Korean J Pediatr 62(8):287\u2013291. https:\/\/doi.org\/10.3345\/kjp.2019.00059","journal-title":"Korean J Pediatr"},{"issue":"1","key":"6442_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5223\/pghn.2022.25.1.1","volume":"25","author":"S Talebi","year":"2022","unstructured":"Talebi S, Heidari F, Taghizadeh S, Imanzadeh F, Alizadeh P, Alizadeh S, Ghaffari J, Moghaddas F, Arjmand B, Mahdavinia M et al (2022) Fecal calprotectin and phenotype severity in patients with cystic fibrosis: a systematic review and meta-analysis. Pediatr Gastroenterol Hepatol Nutr 25(1):1\u201312. https:\/\/doi.org\/10.5223\/pghn.2022.25.1.1","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"issue":"Suppl 3","key":"6442_CR7","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jcf.2014.03.009","volume":"13","author":"S Conway","year":"2014","unstructured":"Conway S, Balfour-Lynn IM, De Rijcke K, Drevinek P, Foweraker J, Havermans T, Heijerman H, Hjelte L, Honore I, Kashirskaya N et al (2014) European cystic fibrosis society standards of care: framework for the cystic fibrosis centre. J Cyst Fibros 13(Suppl 3):S3\u2013S22. https:\/\/doi.org\/10.1016\/j.jcf.2014.03.009","journal-title":"J Cyst Fibros"},{"key":"6442_CR8","doi-asserted-by":"publisher","unstructured":"Castellani C, Cuppens H, Macek M Jr, Cassiman JJ, Kerem E, Durie P, Tullis E, Assael BM, Bombieri C, Brown A et al (2008) Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros 7(3):179\u2013196. https:\/\/doi.org\/10.1016\/j.jcf.2008.03.009","DOI":"10.1016\/j.jcf.2008.03.009"},{"issue":"4","key":"6442_CR9","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/01.MPG.0000072270.77393.4D","volume":"37","author":"UL Fagerberg","year":"2003","unstructured":"Fagerberg UL, L\u00f6\u00f6f L, Merzoug RD, Hansson LO, Finkel Y (2003) Fecal calprotectin levels in healthy children studied with an improved assay. J Pediatr Gastroenterol Nutr 37(4):468\u2013472. https:\/\/doi.org\/10.1097\/01.MPG.0000072270.77393.4D","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"12","key":"6442_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9124080","volume":"9","author":"F Beaufils","year":"2020","unstructured":"Beaufils F, Mas E, Mittaine M, Lamireau T, Munck A, Deneuville E, Michaud L, Gottrand F (2020) Increased fecal calprotectin is associated with worse gastrointestinal symptoms and quality of life scores in children with cystic fibrosis. J Clin Med 9(12):4080. https:\/\/doi.org\/10.3390\/jcm9124080","journal-title":"J Clin Med"},{"issue":"10","key":"6442_CR11","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1007\/s004310050709","volume":"156","author":"L Gullo","year":"1997","unstructured":"Gullo L, Graziano L, Babbini S, Lazzari R, Pezzilli R, Morselli-Labate AM, Cavicchi L (1997) Faecal elastase 1 in children with cystic fibrosis. Eur J Pediatr 156(10):770\u2013772. https:\/\/doi.org\/10.1007\/s004310050709","journal-title":"Eur J Pediatr"},{"issue":"6","key":"6442_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198457","volume":"13","author":"M Brusco de Freitas","year":"2018","unstructured":"Brusco de Freitas M, Moreira EAM, Tomio C, Moreno YMF, Daltoe FP, Reckziegel P, Rodrigues dos Santos E, de Souza LR, Barbosa E, Grzybowski T, Pisani LP (2018) Altered intestinal microbiota composition, antibiotic therapy and intestinal inflammation in children and adolescents with cystic fibrosis. PLoS One. 13(6):e0198457. https:\/\/doi.org\/10.1371\/journal.pone.0198457","journal-title":"PLoS One."},{"issue":"6","key":"6442_CR13","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1016\/j.chest.2020.06.044","volume":"158","author":"A Ishak","year":"2020","unstructured":"Ishak A, Stick SM, Turkovic L, Juang P, Skoric B, Ranganathan S, Schultz A, Kicic A, Hall GL (2020) BAL inflammatory markers can predict pulmonary exacerbations in children with cystic fibrosis. Chest 158(6):2314\u20132322. https:\/\/doi.org\/10.1016\/j.chest.2020.06.044","journal-title":"Chest"},{"issue":"11","key":"6442_CR14","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1513\/AnnalsATS.202111-1266OC","volume":"19","author":"SC Carter","year":"2022","unstructured":"Carter SC, Franciosi AN, O\u2019Shea KM, Kotha K, Doumit M, Tan CD, Clancy JP (2022) Acute pulmonary exacerbation phenotypes in patients with cystic fibrosis. Ann Am Thorac Soc 19(11):1818\u20131826. https:\/\/doi.org\/10.1513\/AnnalsATS.202111-1266OC","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"6442_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1513\/AnnalsATS.202203-201OC","volume":"20","author":"CS Davis","year":"2023","unstructured":"Davis CS, Faino AV, Onchiri F, Brinton JT, Collaco JM, Daines CL, Ren CL (2023) Systemic corticosteroids in the management of pediatric cystic fibrosis pulmonary exacerbations. Ann Am Thorac Soc 20(1):75\u201382. https:\/\/doi.org\/10.1513\/AnnalsATS.202203-201OC","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"6442_CR16","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jcf.2017.03.010","volume":"16","author":"M Garg","year":"2017","unstructured":"Garg M, Leach ST, Coffey MJ, Katz T, Strachan R, Pang T, Needham B, Lui K, Jaffe A, Ooi CY (2017) Age-dependent variation of fecal calprotectin in cystic fibrosis and healthy children. J Cyst Fibros 16(5):631\u2013636. https:\/\/doi.org\/10.1016\/j.jcf.2017.03.010","journal-title":"J Cyst Fibros"},{"issue":"6","key":"6442_CR17","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1136\/archdischild-2023-326221","volume":"109","author":"M Roca","year":"2024","unstructured":"Roca M, Masip E, Colombo C, Gartner S, Salvatore D, Minicucci L, Casciaro R, Carnovale V, Di Lillo M, Majo F, Manzoni G, Padoan R, Parisi G, Seia M, Castellani C (2024) Long-term evaluation of fecal calprotectin levels in a European cohort of children with cystic fibrosis. Arch Dis Child 109(6):552\u2013556. https:\/\/doi.org\/10.1136\/archdischild-2023-326221","journal-title":"Arch Dis Child"},{"issue":"1","key":"6442_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15010162","volume":"15","author":"ME Ritivoiu","year":"2023","unstructured":"Ritivoiu ME, Dr\u0103goi CM, Matei D, Nistor I, Becheanu CA, Cirstoiu MM, Diaconescu S (2023) Current and future therapeutic approaches of exocrine pancreatic insufficiency in children with cystic fibrosis in the era of personalized medicine. Pharmaceutics 15(1):162. https:\/\/doi.org\/10.3390\/pharmaceutics15010162","journal-title":"Pharmaceutics"},{"key":"6442_CR19","doi-asserted-by":"publisher","unstructured":"Liu K, Zhang X, Zhang JT, Zhu L, Fu A, Li W, Wang Y (2016) Defective CFTR-\u03b2-catenin interaction promotes NF-\u03baB nuclear translocation and intestinal inflammation in cystic fibrosis. Oncotarget 7(39):64030\u201364042. https:\/\/doi.org\/10.18632\/oncotarget.11734","DOI":"10.18632\/oncotarget.11734"},{"key":"6442_CR20","doi-asserted-by":"publisher","first-page":"9320","DOI":"10.1038\/s41598-018-27465-3","volume":"8","author":"AR Philp","year":"2018","unstructured":"Philp AR, Riquelme TT, Millar-B\u00fcchner P, Baines M, Looi K, Garratt LW, Kicic A (2018) Kcnn4 is a modifier gene of intestinal cystic fibrosis preventing lethality in the Cftr-F508del mouse. Sci Rep 8:9320. https:\/\/doi.org\/10.1038\/s41598-018-27465-3","journal-title":"Sci Rep"},{"issue":"10","key":"6442_CR21","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1164\/rccm.202204-0734OC","volume":"206","author":"JH Rayment","year":"2022","unstructured":"Rayment JH, Asfour F, Rosenfeld M, McNamara JJ, Szczesniak R, Saiman L, Thompson R (2022) A phase 3, open-label study of lumacaftor\/ivacaftor in children 1 to less than 2 years of age with cystic fibrosis homozygous for F508del-CFTR. Am J Respir Crit Care Med 206(10):1239\u20131247. https:\/\/doi.org\/10.1164\/rccm.202204-0734OC","journal-title":"Am J Respir Crit Care Med"},{"key":"6442_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2018.e01050","volume":"4","author":"F Gonz\u00e1lez-Andrade","year":"2018","unstructured":"Gonz\u00e1lez-Andrade F (2018) Standardized clinical criteria and sweat test combined as a tool to diagnose cystic fibrosis. Heliyon 4:e01050. https:\/\/doi.org\/10.1016\/j.heliyon.2018.e01050","journal-title":"Heliyon"},{"issue":"10","key":"6442_CR23","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1513\/AnnalsATS.201702-121OC","volume":"14","author":"JE Pittman","year":"2017","unstructured":"Pittman JE, Wylie KM, Akers K, Rose SR, Muzny DM, Hager KR, Shen S, Ndao IM, Sodergren E, Weinstock GM (2017) Association of antibiotics, airway microbiome, and inflammation in infants with cystic fibrosis. Ann Am Thorac Soc 14(10):1548\u20131555. https:\/\/doi.org\/10.1513\/AnnalsATS.201702-121OC","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"6442_CR24","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/01.mcp.0000181474.08058.b3","volume":"11","author":"D Borowitz","year":"2005","unstructured":"Borowitz D (2005) Update on the evaluation of pancreatic exocrine status in cystic fibrosis. Curr Opin Pulm Med 11(6):524\u2013527. https:\/\/doi.org\/10.1097\/01.mcp.0000181474.08058.b3","journal-title":"Curr Opin Pulm Med"},{"issue":"2","key":"6442_CR25","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/MPG.0b013e31826f2b71","volume":"56","author":"AC Tardelli","year":"2013","unstructured":"Tardelli AC, Camargos PA, Penna FJ, Goulart EMA, Cardoso ALA, Ribeiro JD, Ribeiro AF (2013) Comparison of diagnostic methods for pancreatic insufficiency in infants with cystic fibrosis. J Pediatr Gastroenterol Nutr 56(2):178\u2013181. https:\/\/doi.org\/10.1097\/MPG.0b013e31826f2b71","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"6442_CR26","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1186\/s12887-024-05154-7","volume":"24","author":"V Terlizzi","year":"2024","unstructured":"Terlizzi V, Fevola C, Castaldo A, Tomaiuolo R, Sepe A, Raia V (2024) Non pathological sweat test, pancreatic insufficiency and cystic fibrosis: an unusual case in a child with F508del-duplication of exons 1\u20133 CFTR genotype. BMC Pediatr 24:752. https:\/\/doi.org\/10.1186\/s12887-024-05154-7","journal-title":"BMC Pediatr"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06442-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-06442-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06442-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:20:45Z","timestamp":1760368845000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-06442-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["6442"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-06442-9","relation":{},"ISSN":["1432-1076"],"issn-type":[{"type":"electronic","value":"1432-1076"}],"subject":[],"published":{"date-parts":[[2025,9,8]]},"assertion":[{"value":"7 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"605"}}